Server:nginx...
X-Powered-By:PHP/5.6.36, PleskLin
The main IP address: 162.13.135.168,Your server United Kingdom,Eton ISP:Cue Media Solutions Ltd. IP Space TLD:uk CountryCode:GB
The description :you are using an outdated browser. please upgrade your browser to improve your experience. contact us search -- about us board members our leadership partners scientific approach gene therapy concept...
This report updates in 02-Jul-2018
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host greatbarjobs.co.uk. Currently, hosted in United Kingdom and its service provider is Cue Media Solutions Ltd. IP Space .
Latitude: | 51.488330841064 |
Longitude: | -0.60904997587204 |
Country: | United Kingdom (GB) |
City: | Eton |
Region: | England |
ISP: | Cue Media Solutions Ltd. IP Space |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx containing the details of what the browser wants and will accept back from the web server.
X-Powered-By: | PHP/5.6.36, PleskLin |
Transfer-Encoding: | chunked |
Set-Cookie: | ci_session=e1vjrpouu1ba95b263clsktok1o8ggkb; expires=Sun, 01-Jul-2018 20:37:48 GMT; Max-Age=7200; path=/; secure; HttpOnly |
Expires: | Thu, 19 Nov 1981 08:52:00 GMT |
Server: | nginx |
Connection: | keep-alive |
Pragma: | no-cache |
Cache-Control: | no-store, no-cache, must-revalidate, post-check=0, pre-check=0 |
Date: | Sun, 01 Jul 2018 18:37:49 GMT |
Content-Type: | text/html; charset=UTF-8 |
soa: | ns.rackspace.com. hostmaster.rackspace.com. 1493715461 86400 7200 604800 300 |
ns: | ns2.rackspace.com. ns.rackspace.com. |
ipv4: | IP:162.13.135.168 ASN:15395 OWNER:RACKSPACE-LON, GB Country:GB |
you are using an outdated browser. please upgrade your browser to improve your experience. contact us search -- about us board members our leadership partners scientific approach gene therapy concept wilson's disease faqs wilson's disease resources unmet medical needs potential benefits of aav gene therapy patient & families resources other liver indications investors work at vivet news & events news events research & publications vivet therapeutics fiercebiotech names vivet therapeutics as one of its 2017 'fierce 15' read more transforming lives novel gene therapies for rare, inherited metabolic diseases read more wilson’s disease benefits of aav gene therapy as a novel approach to manage wilson’s disease read more gene therapy programs a dedicated platform for the development of innovative treatments for inherited liver diseases in collaboration with cima based on aav-anc80 from mee product pipeline targeting life threatening and severely debilitating liver metabolic disorders with high unmet medical need in pediatric and adult patients wilson's disease development of a high-activity atp7b transgene paves the way towards restoring normal copper metabolism in wilson’s disease patients through gene therapy welcome to vivet therapeutics vivet therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases. vivet therapeutics is focused on optimizing gene therapy through collaborating with the fundacion para la investigacion medica aplicada (fima) at the centro de investigación medica aplicada (cima, universidad de navarra) to develop new aav vectors specifically targeting the liver and generating new technologies to optimize gene delivery and long term expression. latest news vivet therapeutics appoints eduardo bravo as new chairman of the board paris, france june 12th, 2018, vivet therapeutics, a biotechnology company developing novel gene therapies for rare, inherited metabolic diseases today… fiercebiotech names vivet therapeutics as one of its 2017 “fierce 15” biotech companies paris, france september 28th, 2017, vivet therapeutics is proud to announce that it has been named by fiercebiotech as one… vivet’s first gene therapy product, vtx 801 for wilson’s disease, receives eu and us odd paris, france september 26th, 2017, vivet therapeutics, announced today that both the food and drug administration (fda) and the european… fda news : cellular & gene therapy guidances a useful resource of cellular & gene therapy guidance documents ema news this section of the website provides information for companies and individuals involved in developing and marketing medicines for human use… gene therapy of liver diseases in europe, a disease is defined as rare when it affects fewer than one out of every 2,000 people. however,… vivet therapeutics raises €37.5 million in series a financing round vivet therapeutics raises €37.5 million in series a financing round to advance novel gene therapies for treating inherited metabolic diseases top sign up to stay in touch submit contact us vivet therapeutics 29 rue tronchet 75008 paris, france [email protected] 01234 567 890 -- our site uses cookies. to find out what cookies we use and why we use them click here . if you carry on using our site we will assume you consent to us using cookies in this way. ') english español français --
https://www.vivet-therapeutics.com/en/en/news-events/latest/ema-news
https://www.vivet-therapeutics.com/en/en/news-events/latest/fda-news
https://www.vivet-therapeutics.com/en/#0
https://www.vivet-therapeutics.com/en/en/gene-therapy-concept/other-liver-indications
https://www.vivet-therapeutics.com/en/en/news-events/events
https://www.vivet-therapeutics.com/en/es
https://www.vivet-therapeutics.com/en/en/search
https://www.vivet-therapeutics.com/en/en/news-events/research-publications
https://www.vivet-therapeutics.com/en/en/gene-therapy-concept/wilsons-disease-resources/patient-families-resources
https://www.vivet-therapeutics.com/en/en/about-us
https://www.vivet-therapeutics.com/en/en/investors
https://www.vivet-therapeutics.com/en/en/scientific-approach
https://www.vivet-therapeutics.com/en/en/gene-therapy-concept/wilsons-disease-faqs
https://www.vivet-therapeutics.com/en/en/news-events/news
https://www.vivet-therapeutics.com/en/en/home
raredesign.co.uk
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Error for "greatbarjobs.co.uk".
the WHOIS query quota for 2600:3c03:0000:0000:f03c:91ff:feae:779d has been exceeded
and will be replenished in 214 seconds
WHOIS lookup made at 22:58:13 06-Oct-2017
--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REFERRER http://www.nominet.org.uk
REGISTRAR Nominet UK
SERVERS
SERVER co.uk.whois-servers.net
ARGS greatbarjobs.co.uk
PORT 43
TYPE domain
DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REGISTERED no
DOMAIN
NAME greatbarjobs.co.uk
NSERVER
NS2.RACKSPACE.COM 65.61.188.4
NS.RACKSPACE.COM 69.20.95.4
The following list shows you to spelling mistakes possible of the internet users for the website searched .